$IVC (Invacare Corporation)

$IVC {{ '2016-10-03T11:18:48+0000' | timeago}} • Announcement

$IVC said the company has completed the sale of its subsidiary, Garden City Medical, Inc., dba PMI and Pinnacle Medsource to Compass Health Brands for approx. $13.8MM in cash. As part of the transition, $IVC will discontinue selling the ProBasics products after a 15-day transition period.

$SYK {{ '2018-01-09T17:21:37+0000' | timeago}} • Announcement

$SYK said that for 4Q17 its preliminary results are of net sales growth of 10% to $3.5Bil, while for FY17, its net sales grew 9.9% to $12.4Bil. Excluding the impact of foreign currency & acquisitions, net sales rose 8.1% and 7.1% in 4Q17 and FY17. For 2018, $SYK expects modest headwinds that will be manageable within its overall financial targets.

$HRC {{ '2018-01-09T17:07:14+0000' | timeago}} • Announcement

$HRC announced its preliminary 1Q18 revenue. For this period, the company expects worldwide revenue of approx $670MM, an increase of 5% YoY. Core revenue increased approx 2%, exceeding the company's previously issued guidance of flat core revenue growth.

$AIT {{ '2018-01-09T14:46:20+0000' | timeago}} • Announcement

$AIT has agreed to acquire FCX Performance, Inc. for approx. $768MM. The deal is expected to close within 30 days. The acquisition is expected to contribute about $550MM in sales and $68MM in EBITDA in the first 12 months of applied ownership. The deal is expected to be accretive in FY19 after recognition of one-time transaction costs in FY18.

$LLY {{ '2018-01-08T19:33:20+0000' | timeago}} • Announcement

$LLY join hands with consumer digital health company Livongo Health to study real world behaviors of people affected with diabetes. This collaboration is expected help the diabetic people to better manage their condition.

$COO {{ '2018-01-04T21:58:01+0000' | timeago}} • Announcement

$COO declared a semi-annual dividend of $0.03 per share, payable on February 9, 2018, to stockholders of record on January 23, 2018.

$CI {{ '2017-12-15T12:13:02+0000' | timeago}} • Announcement

$CI acquired Brighter Inc., a platform that connects patients, providers, and payers. $CI expects Brighter’s digital health plan platform will help to accelerate and expand the consumer initiatives. The financial details of the deal remained undisclosed.

$LLY {{ '2017-12-14T18:20:39+0000' | timeago}} • Announcement

$LLY join hands with diabetes management firm Rimidi to provide personalized solutions for diabetic patients who are using insulin. As per the agreement, Rimidi's diabetes management software platform will be integrated with Lilly's insulin management system which is in development.

$CYH {{ '2017-12-14T13:11:35+0000' | timeago}} • Announcement

$CYH elected Michael Dinkins and Ranga Krishnan to the Board of Directors for terms that will expire at the 2018 Annual Meeting of Stockholders. As part of a settlement in a derivative action lawsuit finalized in January 2017, the company sought the names of prospective candidates for the BoD from its stockholders.

$LLY {{ '2017-12-13T17:55:28+0000' | timeago}} • Announcement

For 2017, $LLY cut down its GAAP EPS outlook and confirmed its non-GAAP EPS and revenue targets. New products and volume are estimated to drive the low-single digit revenue growth in 2018. Eli Lilly expects to make regulatory progress in 2018 on its rheumatoid arthritis drug baricitinib and migraine drug galcanezumab.

$SYK {{ '2017-12-12T14:28:46+0000' | timeago}} • Announcement

$SYK said Howard Cox Jr. has notified the company that he will not stand for re-election at Stryker's 2018 Annual Meeting, which is expected to be held on May 2, 2018. In light of Cox's immense contributions to the company, he will be named Director Emeritus.

$HLS {{ '2017-12-12T13:23:46+0000' | timeago}} • Announcement

$HLS appointed Nancy Schlichting as an independent director, effective Dec. 11, 2017. With this appointment, the Board will expand to 11 directors. Schlichting currently serves on the boards of $WBA and $HRC.

$SYK {{ '2017-12-11T21:53:53+0000' | timeago}} • Announcement

$SYK said that the simplified public tender offer for the shares and BSAAR warrants of VEXIM has closed. $SYK, which already owned over 50% of the share capital and voting rights of VEXIM, acquired an additional 4.04MM shares during the offer period, as well as 226,520 BSAAR warrants that it has exercised for new shares of VEXIM.

$LLY {{ '2017-12-11T21:06:46+0000' | timeago}} • Announcement

$LLY raised its 1Q18 dividend by 8% to $0.5625 per stock. The dividend is payable on March 9, 2018 to shareholders of record as of Feb. 15, 2018.

$LLY {{ '2017-12-11T17:36:13+0000' | timeago}} • Announcement

FDA accepts to review $LLY's Galcanezumab, an injectionable drug for the treatment of migraine. Rivals $NVS and $AMGN already filed their migraine drug with FDA in July 2017, while $TEVA is also expected to join the race. Lilly's pain portfolio also includes Tanezumab, developed in partnership with $PFE, for the treatment of osteoarthritis.

$LLY {{ '2017-12-11T17:32:54+0000' | timeago}} • Announcement

Kimberly Blackwell, a breast cancer researcher, will be joining $LLY's Oncology division as VP of early phase development and immuno-oncology on March 12, 2018. Dr. Blackwell currently serves as professor of medicine and assistant professor of radiation oncology at Duke University Medical Center.

$ANTM {{ '2017-12-11T14:59:25+0000' | timeago}} • Infographic

At a time when the US health insurance sector stares at a rise in premium prices, amid the government’s move to repeal the Individual Mandate clause, an analysis shows that major players in the sector registered consistent revenue growth over the past ten years. $ANTM $UNH $AET $HUM $CI

$ENTL {{ '2017-12-08T17:39:22+0000' | timeago}} • Announcement

Rowley Law PLLC is investigating potential claims against $ENTL and its BoD for breach of fiduciary duty concerning the proposed acquisition of the company by $SYK. Stockholders will receive $24.00 in cash for each share of $ENTL that they hold. The transaction is valued at about $662MM.

$COO {{ '2017-12-08T14:45:01+0000' | timeago}} • Webcast

$COO said the Procornea and Paragon acquisitions are part of its specialty lens business. These two businesses combined are expected to bring in about $30MM in revenues. The company believes the specialty lens business is growing in the upper single-digit, if not double-digit range. $COO is optimistic about the growth of this business in future.

$COO {{ '2017-12-08T14:43:23+0000' | timeago}} • Webcast

$COO recently purchased an existing manufacturing facility in Costa Rica for its CooperSurgical business to consolidate a significant portion of its global manufacturing. $COO has made progress upgrading the facility and hiring employees and plans to begin production of the Wallace Transfer Catheter in the near future.

$COO {{ '2017-12-08T14:43:09+0000' | timeago}} • Webcast

$COO's CooperVision business posted 4Q17 revenues of $439MM, up 7% as reported and up 5% pro forma. Daily silicone hydrogel lenses drove growth up 37% in constant currency. The CooperSurgical business posted revenues of $123MM, up 15% as reported and up 7% pro forma. Fertility drove growth up 28% as reported.

Recent Transcripts

SCHN (Schnitzer Steel Industries, Inc.)
Tuesday, January 9 2018 - 4:30pm
SHLO (Shiloh Industries Inc.)
Friday, January 5 2018 - 1:00pm
COO (The Cooper Companies Inc.)
Thursday, December 7 2017 - 10:00pm
IVC (Invacare Corporation)
Wednesday, November 8 2017 - 1:30pm
DVA (DaVita HealthCare Partners Inc.)
Tuesday, November 7 2017 - 10:00pm
INGN (Inogen, Inc.)
Tuesday, November 7 2017 - 9:30pm
CVS (CVS Health Corporation)
Monday, November 6 2017 - 1:30pm
HRC (Hill-Rom Holdings, Inc.)
Friday, November 3 2017 - 12:00pm
CYH (Community Health Systems, Inc.)
Thursday, November 2 2017 - 3:00pm
RTIX (RTI Surgical Inc.)
Thursday, November 2 2017 - 12:30pm
CI (Cigna Corp.)
Thursday, November 2 2017 - 12:30pm
WMGI (Wright Medical Group N.V.)
Wednesday, November 1 2017 - 8:30pm
RDY (Dr. Reddy's Laboratories Ltd.)
Tuesday, October 31 2017 - 1:00pm
CRY (CryoLife Inc.)
Tuesday, October 31 2017 - 12:00pm
SYK (Stryker Corporation)
Thursday, October 26 2017 - 8:30pm
TRS (TriMas Corporation)
Thursday, October 26 2017 - 2:00pm
AIT (Applied Industrial Technologies, Inc.)
Wednesday, October 25 2017 - 2:00pm
EW (Edwards Lifesciences Corp.)
Tuesday, October 24 2017 - 9:00pm
SCHN (Schnitzer Steel Industries, Inc.)
Tuesday, October 24 2017 - 3:30pm
LLY (Eli Lilly and Company)
Tuesday, October 24 2017 - 1:00pm

AlphaGraphics you may like